Search alternatives:
significant substantial » significant potential (Expand Search), significant spatial (Expand Search)
substantial decrease » substantial increase (Expand Search), substantially increased (Expand Search)
role decrease » rate decreased (Expand Search), road decreased (Expand Search), note decreased (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
Showing 141 - 160 results of 23,402 for search '(( significant ((role decrease) OR (fold decrease)) ) OR ( significant substantial decrease ))', query time: 1.33s Refine Results
  1. 141
    Lymphocyte subset distribution during longitudinal follow-up in JSLE patients, stratified into treatment-naïve and treated groups.

    Lymphocyte subset distribution during longitudinal follow-up in JSLE patients, stratified into treatment-naïve and treated groups. by Butsabong Lerkvaleekul (12055191)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  2. 142
    Regulatory T cells in JSLE patients during 6-months follow-up.

    Regulatory T cells in JSLE patients during 6-months follow-up. by Butsabong Lerkvaleekul (12055191)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  3. 143
    Kaplan–Meier analysis of clinical remission in juvenile-onset systemic lupus erythematosus patients.

    Kaplan–Meier analysis of clinical remission in juvenile-onset systemic lupus erythematosus patients. by Butsabong Lerkvaleekul (12055191)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  4. 144
    Differences among lymphocyte subsets between JSLE patients and HC.

    Differences among lymphocyte subsets between JSLE patients and HC. by Butsabong Lerkvaleekul (12055191)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  5. 145
    Associations between lymphocyte subsets and clinical manifestations in juvenile-onset systemic lupus erythematosus.

    Associations between lymphocyte subsets and clinical manifestations in juvenile-onset systemic lupus erythematosus. by Butsabong Lerkvaleekul (12055191)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  6. 146
    Predictors of remission on therapy in the juvenile-onset systemic lupus erythematosus patients.

    Predictors of remission on therapy in the juvenile-onset systemic lupus erythematosus patients. by Butsabong Lerkvaleekul (12055191)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  7. 147
    Demographic, clinical, and laboratory parameters of the juvenile-onset systemic lupus erythematosus patients.

    Demographic, clinical, and laboratory parameters of the juvenile-onset systemic lupus erythematosus patients. by Butsabong Lerkvaleekul (12055191)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  8. 148
    Stratification of the juvenile-onset systemic lupus erythematosus patients by the median percentage of each lymphocyte subset.

    Stratification of the juvenile-onset systemic lupus erythematosus patients by the median percentage of each lymphocyte subset. by Butsabong Lerkvaleekul (12055191)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  9. 149
    Lymphocyte subset distribution during longitudinal follow-up in JSLE patients.

    Lymphocyte subset distribution during longitudinal follow-up in JSLE patients. by Butsabong Lerkvaleekul (12055191)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  10. 150
    Percentages of lymphocyte subsets in the juvenile-onset systemic lupus erythematosus patients.

    Percentages of lymphocyte subsets in the juvenile-onset systemic lupus erythematosus patients. by Butsabong Lerkvaleekul (12055191)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  11. 151
    Cardiac miRNAs significantly upregulated by DSS colitis.

    Cardiac miRNAs significantly upregulated by DSS colitis. by Yanbo Tang (11457519)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  12. 152
    Phase 2 significant effects.

    Phase 2 significant effects. by Wendy C. Crone (2262169)

    Published 2023
    Save to List
    Saved in:
  13. 153
    Phase 1 significant effects.

    Phase 1 significant effects. by Wendy C. Crone (2262169)

    Published 2023
    Save to List
    Saved in:
  14. 154
    Data_Sheet_2_Serological Levels of Anti-clathrin Antibodies Are Decreased in Patients With Pseudoexfoliation Glaucoma.docx

    Data_Sheet_2_Serological Levels of Anti-clathrin Antibodies Are Decreased in Patients With Pseudoexfoliation Glaucoma.docx by Vanessa M. Beutgen (6432671)

    Published 2021
    Save to List
    Saved in:
  15. 155
    Data_Sheet_1_Serological Levels of Anti-clathrin Antibodies Are Decreased in Patients With Pseudoexfoliation Glaucoma.docx

    Data_Sheet_1_Serological Levels of Anti-clathrin Antibodies Are Decreased in Patients With Pseudoexfoliation Glaucoma.docx by Vanessa M. Beutgen (6432671)

    Published 2021
    Save to List
    Saved in:
  16. 156
    Butyrate was decreased in the NAFLD patients and OH mice.

    Butyrate was decreased in the NAFLD patients and OH mice. by Limin Liu (201430)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  17. 157
    Cell proliferation was significantly decreased in full-length HPV16 E1 (pEGFP-E1) transfected cells.

    Cell proliferation was significantly decreased in full-length HPV16 E1 (pEGFP-E1) transfected cells. by Fern Baedyananda (11888703)

    Published 2021
    Save to List
    Saved in:
  18. 158
    <i>neurod1</i><sup><i>ΔUCE</i></sup> homozygous mutants display a decrease in the expression of several EE hormones.

    <i>neurod1</i><sup><i>ΔUCE</i></sup> homozygous mutants display a decrease in the expression of several EE hormones. by Anne Sophie Reuter (12239993)

    Published 2022
    Save to List
    Saved in:
  19. 159
    Genes showing 1.5 fold expression decrease in D381 relative to heterozygous <i>TOR1/tor1</i>.

    Genes showing 1.5 fold expression decrease in D381 relative to heterozygous <i>TOR1/tor1</i>. by Wanjun Qi (5571359)

    Published 2022
    Save to List
    Saved in:
  20. 160
    The expression of <i>Collagen II</i> and <i>Collagen X</i> in cartilage cells were significantly decreased after siRNA treatment.

    The expression of <i>Collagen II</i> and <i>Collagen X</i> in cartilage cells were significantly decreased after siRNA treatment. by Fei Ye (339913)

    Published 2019
    Save to List
    Saved in:

Search Tools: